drugset / Trial / NCT02016391

Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours

NCT02016391 ↗

Phase 4 Completed 50 enrolled Uppsala University Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of he study is to evaluate effects of dexmedetomidine on pain during radiofrequency ablation of liver and kidney tumours.

Timeline

Start
2013-12
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg Other